NRP1 and COVID-19: Finally, it is hypothesized that, especially in people who had multiple infections with SARS-CoV-2, the increased expression of NRP-1 caused by COVID-19 may play an important role in long-term clinical problems related to the CNS and may accelerate the development of brain tumors at the preliminary stage [73].